Cellino to Address iPSC Manufacturing Challenges at Kyoto Conference
Event summary
- Cellino's CPO Marinna Madrid, Ph.D., to speak at Keystone Symposia conference in Kyoto on January 28, 2026.
- Conference marks 20th anniversary of iPSC technology discovery.
- Madrid's presentation focuses on industrial-scale manufacturing solutions for personalized cell therapies.
- Event features Nobel Laureate Dr. Shinya Yamanaka as keynote speaker.
The big picture
The conference highlights the 20-year evolution of iPSC technology, now moving from research to clinical applications. Cellino's participation underscores the critical need for manufacturing advancements to make personalized therapies commercially viable. The event brings together key stakeholders in regenerative medicine, signaling growing industry collaboration to overcome technical and ethical challenges in cell-based therapies.
What we're watching
- Manufacturing Breakthroughs
- How Cellino's automation solutions will impact the scalability of personalized cell therapies.
- Regulatory Landscape
- Whether FDA's Advanced Manufacturing Technology designation will accelerate Cellino's commercialization timeline.
- Industry Collaboration
- The pace at which academic-industry partnerships will drive next-generation cell therapy innovations.
Related topics